Public-Private German Seed Fund Celebrates Major Exit
The High-Tech Gründerfonds (HTGF) will sell its shares in start-up Cardior Pharmaceuticals as part of a billion-euro acquisition by industry giant Novo Nordisk.
Your company is already operating in Germany and you would now like to export worldwide?
The High-Tech Gründerfonds (HTGF) will sell its shares in start-up Cardior Pharmaceuticals as part of a billion-euro acquisition by industry giant Novo Nordisk.
The Japanese pharmaceutical giant will expand its Pfaffenhofen location in southern Germany into an international innovation center.
Meet our team at DMEA 2024 from April 09 - 11
Germany’s healthcare sector enjoyed a successful year with a resurgent biotech sector generating a quarter of new capital. New therapies are being developed for a range of autoimmune diseases and telemedicine service are on the rise.
The injectable Mounjaro that will be mass produced by Eli Lilly and Company in Germany has been cleared for use in helping people shed pounds.
In 2023, there was a notable resurgence in the financing available to Germany's biotechnology sector.
Germany is undertaking a “digital revolution” in healthcare and now has a strategy to make life easier for pharmaceutical companies.
American pharmaceutical company Lilly will construct a USD 2.5 billion high-tech production site in Alzey in the west of Europe’s largest healthcare market.
MEDICA 2023, the world-leading information and communication platform for the medical technology industry and supplier industry took place in November.
The 2022 Top 100 of medium-sized German companies with the best growth prospects shows a clear trend toward a trio of sectors.